2025-06-04Niranjan Ghatule
Sun Pharma Advanced Research Company (SPARC) shares hit a 20% lower circuit after its much-hyped drug candidate SCD-044 failed in Phase 2 clinical trials. The management had earlier given a strong positive commentary about the drug’s potential, calling it a game-changer.
View more
2025-05-19Niranjan Ghatule
Protean e-Governance Technologies is currently facing a major crisis as it has been removed from the Income Tax Department’s list of managed service providers for PAN card processing. This has led to a sharp fall in its stock price, hitting a 52-week low and triggering a lower circuit at ₹1,143 on the NSE.
View more
Your experience on this site will be improved by allowing cookies
Cookie Policy